Jci_page_head_homepage_01 Jci_page_head_homepage_02
Marc Feldmann
Published in Volume 118, Issue 11
J Clin Invest. 2008; 118(11):3533 doi:10.1172/JCI37346
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2011 2010 2009 Total
Citations: 4 10 7 21

Citations to this article in CrossRef (21)

Title and authors Publication Year
Sasa quelpaertensis Phenylpropanoid Derivative Suppresses Lipopolysaccharide-induced Nitric Oxide Synthase and Cyclo-oxygenase-2 Expressions in RAW 264.7 Cells
Ji-Young MOON, Eun-Jin YANG, Sang Suk KIM, Ji-Yong KANG, Gi-Ok KIM, Nam Ho LEE, Chang-Gu HYUN
YAKUGAKU ZASSHI 2011
Cytokines in rats experimentally infected with Trypanosoma evansi
Francine C. Paim, Marta M.M.F. Duarte, Márcio M. Costa, Aleksandro S. Da Silva, Patrícia Wolkmer, Cássia B. Silva, Carlos B.V. Paim, Raqueli T. França, Cinthia M.A. Mazzanti, Silvia G. Monteiro, Alexandre Krause, Sonia T.A. Lopes
Experimental Parasitology 2011
Modulation of Cytokine and Cytokine Receptor/Antagonist by Treatment with Doxycycline and Tetracycline in Patients with Dengue Fever
J. E. Z. Castro, I. Vado-Solis, C. Perez-Osorio, T. M. Fredeking
Clinical and Developmental Immunology 2011
Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice
T. Bohgaki, J. Mozo, L. Salmena, E. Matysiak-Zablocki, M. Bohgaki, O. Sanchez, A. Strasser, A. Hakem, R. Hakem
The Journal of Cell Biology 2011
Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: Does variable inhibition of interleukin-6 production limit effectiveness in vivo?
Theresa H. Page, Anthony Brown, Emma M. Timms, Brian M. J. Foxwell, Keith P. Ray
Arthritis Rheum 2010
Vaccines against non-communicable diseases
Till A Röhn, Martin F Bachmann
Current Opinion in Immunology 2010
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines
Alexander Link, Martin F Bachmann
Immunotherapy 2010
Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market
Chung-Jr Huang, Adam J. Lowe, Carl A. Batt
Appl Microbiol Biotechnol 2010
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation
Katherine L. Meyer-Siegler, Jacob Cox, Lin Leng, Richard Bucala, Pedro L. Vera
Cancer Letters 2010
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Melanie S. Joy, Debbie S. Gipson, Leslie Powell, Jacqueline MacHardy, J. Charles Jennette, Suzanne Vento, Cynthia Pan, Virginia Savin, Allison Eddy, Agnes B. Fogo, Jeffrey B. Kopp, Daniel Cattran, Howard Trachtman
American Journal of Kidney Diseases 2010